What is serotonin syndrome and which medications can cause it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

What is Serotonin Syndrome?

Serotonin syndrome is a potentially fatal condition caused by elevated brain serotonin levels, characterized by a clinical triad of mental status changes, neuromuscular hyperactivity, and autonomic hyperactivity that typically arises within 24-48 hours after combining serotonergic medications. 1

Clinical Presentation

The syndrome manifests across three key domains 1, 2:

Mental Status Changes

  • Confusion
  • Agitation
  • Anxiety

Neuromuscular Hyperactivity

  • Tremors and clonus (highly diagnostic)
  • Hyperreflexia
  • Muscle rigidity
  • Myoclonus (occurs in 57% of cases) 2

Autonomic Hyperactivity

  • Hypertension and tachycardia
  • Arrhythmias
  • Tachypnea
  • Diaphoresis (sweating)
  • Shivering
  • Vomiting and diarrhea

Advanced/Severe Symptoms

Advanced cases can progress to fever, seizures, arrhythmias, unconsciousness, rhabdomyolysis, metabolic acidosis, renal failure, and death 1, 2. The mortality rate is approximately 11% 2.

Medications That Can Cause Serotonin Syndrome

Highest Risk: MAOIs (Avoid Combinations)

Monoamine oxidase inhibitors play a role in most cases of serotonin syndrome and should be avoided in combination with ANY other serotonergic drug 1. These include:

  • Phenelzine
  • Isocarboxazid
  • Moclobemide
  • Isoniazid
  • Linezolid

Antidepressants

  • SSRIs (fluoxetine, paroxetine, sertraline, citalopram, escitalopram, fluvoxamine) 1
  • SNRIs (serotonin-norepinephrine reuptake inhibitors) 1
  • TCAs (tricyclic antidepressants) 1
  • Atypical antidepressants 1

Opioids and Pain Medications (Critical to Recognize)

  • Tramadol (particularly high risk) 1, 3
  • Meperidine 1
  • Methadone 1
  • Fentanyl 1, 3

Stimulants

  • Amphetamine class 1
  • Possibly methylphenidate 1

Over-the-Counter and Common Medications

  • Dextromethorphan (cough suppressant) 1
  • Chlorpheniramine (antihistamine) 1

Supplements and Illicit Drugs

  • St. John's wort 1
  • L-tryptophan 1
  • Diet pills 1
  • Ecstasy (MDMA) 1
  • Methamphetamine 1
  • Cocaine 1
  • LSD 1

Critical Clinical Pitfalls

The combination of SSRIs with MAOIs is contraindicated due to increased risk of serotonin syndrome 1. However, clinicians often overlook that linezolid (an antibiotic) is an MAOI and poses the same risk 3.

When combining two or more non-MAOI serotonergic drugs, start the second drug at a low dose, increase slowly, and monitor closely for symptoms, especially in the first 24-48 hours after dosage changes 1. This is particularly important with:

  • SSRI + tramadol or fentanyl combinations 3
  • SSRI + SNRI combinations 3
  • Trazodone combinations (identified as highly connected in drug interaction networks) 4

Management

Treatment is hospital-based and includes immediate discontinuation of all serotonergic agents and supportive care with continuous cardiac monitoring 1.

Mild Cases

  • Discontinue or reduce the serotonergic agent
  • Observation

Moderate to Severe Cases

  • Benzodiazepines for agitation 2
  • External cooling for hyperthermia 2
  • IV fluids for autonomic instability 2

Life-Threatening Cases (Temperature >41.1°C)

  • Emergency sedation
  • Neuromuscular paralysis
  • Intubation and mechanical ventilation 2
  • Avoid physical restraints (they worsen hyperthermia and lactic acidosis through isometric contractions) 2

Adjunctive Pharmacotherapy

Cyproheptadine (a serotonin2A antagonist) may be considered, though evidence for effectiveness is limited to case reports 2, 5. The cornerstone of treatment is early aggressive supportive care, not antidote administration 5.

References

1
Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

3
Research

Selective Serotonin Reuptake Inhibitors and Risk of Serotonin Syndrome as Consequence of Drug-Drug Interactions: analysis of The FDA Adverse Event Reporting System (FAERS).

Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2025

5
Research

[Not Available].

British journal of clinical pharmacology, 2024

Related Questions

In a patient taking a selective serotonin reuptake inhibitor (SSRI), which opioid—hydrocodone (often combined with acetaminophen) or Percocet (oxycodone/acetaminophen)—is more likely to precipitate serotonin syndrome?
How should pathological intoxication induced by an SSRI be managed?
What is serotonin syndrome, including its causes, clinical presentation, diagnostic criteria, and management?
What are the clinical manifestations of serotonin syndrome?
What are the recommended protocols for the management of serotonin syndrome?
Can hypernatremia cause fixed or non‑reactive pupils?
What is the appropriate management of acute liver failure due to leptospirosis?
What is the recommended treatment for enterocolitis in a cancer patient?
What is the appropriate dosing and administration schedule for omalizumab (generic) in patients with allergic bronchopulmonary aspergillosis (ABPA)?
Is Tazocin (piperacillin/tazobactam) safe to use in a patient with epilepsy and hypernatremia?
Can rheumatic heart disease be diagnosed using a two-dimensional echocardiogram?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.